Emerging from the shadow of COVID-19We now have a unique opportunity to re-discover what matters most to patients, says Alnylam’s Kasha Witkos. In Share XEmerging from the shadow of COVID-19https://deep-dive.pharmaphorum.com/magazine/patients-partnerships/biotech-alnylam-shadow-of-covid-19/
